Summary
Bone Densitometers (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on theBone Densitometers market for the year 2020 and beyond. Bone Densitometers harness X-rays to examine and quantify a patient's bone density. Bone density tests are used to assess fracture risk, investigate height loss, diagnose and monitor osteoporosis, and monitor steroid treatment (or other drugs that may affect bone density such as anti-organ rejection medication). DXA machines are the gold-standard for bone densitometry. ADEXA machines are an important tool for assessing fracture risk in fragile areas of the body in osteoporosis patients, such as the hip and spine.
Although they are more expensive, they are more equipped to handle these areas of the body. PDEXA machines, which are smaller, less expensive and portable are less sought after, though they are far more useful the peripheral anatomies such as hands and ankles. QUS machines are also less commonly used, although they are very useful for monitoring regular patients.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Bone Densitometers and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: GE Healthcare LLC, Hologic Inc, Diagnostic Medical Systems SA, Norland
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
Reasons to Buy
The Model will enable you to -
Bone Densitometers (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on theBone Densitometers market for the year 2020 and beyond. Bone Densitometers harness X-rays to examine and quantify a patient's bone density. Bone density tests are used to assess fracture risk, investigate height loss, diagnose and monitor osteoporosis, and monitor steroid treatment (or other drugs that may affect bone density such as anti-organ rejection medication). DXA machines are the gold-standard for bone densitometry. ADEXA machines are an important tool for assessing fracture risk in fragile areas of the body in osteoporosis patients, such as the hip and spine.
Although they are more expensive, they are more equipped to handle these areas of the body. PDEXA machines, which are smaller, less expensive and portable are less sought after, though they are far more useful the peripheral anatomies such as hands and ankles. QUS machines are also less commonly used, although they are very useful for monitoring regular patients.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Bone Densitometers and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Bone Densitometers market revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, the publisher's analysts provide unique country specific insights on the market.
- SWOT analysis for Bone Densitometers market.
- Competitive dynamics insights and trends provided for Bone Densitometers market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: GE Healthcare LLC, Hologic Inc, Diagnostic Medical Systems SA, Norland
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Bone Densitometers marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The Model will enable you to -
- Understand the impact of COVID-19 on theBone Densitometers market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Bone Densitometers market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bone Densitometers market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Bone Densitometers market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GE Healthcare LLC
- Hologic Inc
- Diagnostic Medical Systems SA
- Norland